L. A. McDermott - Concepedia

Author

L. A. McDermott

Also Known As

D William, L A McDermott, L McDermott, L. A. MCDERMOTT, L. A. McDERMOTT, L. A. McDermott, L.A. McDermott, LAURA MCDERMOTT, Laura A McDermott, Laura A. McDermott

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Tufts Medical Center Tufts University University of Michigan Duke Medical Center Loyola University Medical Center

About

L. A. McDermott is an author at Tufts Medical Center specializing in medicine, microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	828
2	Health Sciences	10	10	555
3	Biology	3	3	84
4	Engineering	1	1	11
5	Public Health	1	1	34

L. A. McDermott

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
National Survey on the Susceptibility of <i>Bacteroides fragilis</i> Group: Report and Analysis of Trends in the United States from 1997 to 2004 David R. Snydman, N V Jacobus, L. A. McDermott, Antimicrobial Agents and Chemotherapy	2007	168
Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009 David R. Snydman, N V Jacobus, L. A. McDermott, Anaerobe Related SpeciesSpecial AttentionAntimicrobial Resistance GeneAntimicrobial SusceptibilityHealth Sciences	2011	117
Multicenter Study of In Vitro Susceptibility of the <i>Bacteroides fragilis</i> Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996 David R. Snydman, N V Jacobus, L. A. McDermott, Antimicrobial Agents and Chemotherapy	1999	107
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? David Oxman, Jennifer Chow, György Frendl, Journal of Antimicrobial Chemotherapy	2010	107
Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens David R. Snydman, N V Jacobus, L. A. McDermott, Antimicrobial Agents and Chemotherapy	2000	102
Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009 David R. Snydman, N V Jacobus, L. A. McDermott, Anaerobe Antimicrobial Resistance GeneAntimicrobial SusceptibilityParabacteroides SpeciesAntibioticsBacteroides Species	2016	77
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin David R. Snydman, L. A. McDermott, N V Jacobus, Antimicrobial Agents and Chemotherapy Pathogen DetectionBacterial PathogensUnited StatesDrug ResistanceAntimicrobial Stewardship	2015	65
In Vitro Activities of Tigecycline against the <i>Bacteroides fragilis</i> Group N V Jacobus, L. A. McDermott, Robin Ruthazer, Antimicrobial Agents and Chemotherapy B. Fragilis GroupAntimicrobial ChemotherapyBacterial PathogensVitro ActivitiesDrug Resistance	2004	65
Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis David R. Snydman, G J Cuchural, L. A. McDermott, Antimicrobial Agents and Chemotherapy Antimicrobial SusceptibilityGeometric Mean MicAntibioticsHealthcare-associated InfectionRetrospective Analysis	1992	55
Evaluation of the <i>In Vitro</i> Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates David R. Snydman, L. A. McDermott, N V Jacobus, Antimicrobial Agents and Chemotherapy	2018	52

Page 1